Skip to NavigationSkip to content

Pharmafile - Medical Communications

Europe extends Invokana indication to cover diabetic kidney disease in type 2 diabetes patients
European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium ...
US anti-racism protests did not cause spike in coronavirus cases, new study shows
Widespread protests against racism and police brutality did not cause a significant spike in coronavirus cases in the US, according to new research.
Promising early immunogenicity data for Pfizer and BioNTech's COVID vaccine candidate
Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part of their BNT162 RNA-based...
Texas mandates the wearing of facemasks in public
Texas becomes the latest state in the US to mandate the wearing of facemasks in public, as COVID-19 cases skyrocket across the country.
>> More Medical Communications News Stories

Features

How is COVID-19 impacting the rare disease community?

The COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But what does it...

>> More Features

Appointments

Mundipharma names Marc Princen as Global Chief Executive Officer

Marc Princen was revealed in mid-June as the new Global Chief Executive Officer (CEO) of the Mundipharma network, having taken up the role...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches